摘要
拟盐皮质激素增多综合征(AME)是由11β-羟基类固醇脱氢酶2基因突变引起的一种常染色体隐性遗传病,多于新生儿及成年期发病.该病由Werde等1977年首次报道,以低肾素型高血压、低醛固酮血症、代谢性碱中毒、高钠血症、低钾血症为临床特征.近年来,随着临床诊断水平特别是基因检测水平的提高, AME陆续被发现.现对AME的发病机制、临床表现、诊断和治疗等方面的研究进展进行综述,以进一步提高对该病的认识,为其临床诊治提供参考.
Apparent mineralocorticoid excess(AME) is an autosomal recessive inheritance caused by 11β-hydroxysteroid dehydrogenase 2 gene mutation.It may occur in newborn and adult.AME was first reported in 1977 by Werder et al.Its clinical features include hyporenin type hypertension, hypoaldosteronemia, metabolic alkalosis, hypernatremia and hypokalemia.In recent years, with the improvement of clinical diagnosis, especially gene detection, AME has been reported one after another.In this paper, the pathogenesis, clinical manifestation, diagnosis and therapy of AME were reviewed in order to improve the understanding of this disease and provide reference for its clinical diagnosis and treatment.
作者
徐琳
王广新
朱英翠
苏国海
Xu Lin;Wang Guangxin;Zhu Yingcui;Su Guohai(Department of Cardiology,Ji/ nan Central Hospital Affiliated to Shandong University,Jinan,Shandong 250013 ,China;Clinical College of Weifang Medical University t Weifang,Shandong 261053 ,China)
出处
《中国基层医药》
CAS
2019年第20期2552-2555,共4页
Chinese Journal of Primary Medicine and Pharmacy
基金
国家自然科学基金项目(81170087).
关键词
盐皮质激素过多综合征
表观
病因学
诊断
治疗
高血压
高钠血症
低钾血症
突变
Mineralocorticoid excess syndrome, apparent
Etiology
Diagnosis
Therapy
Hypertension
Hypernatremia
Hypokalemia
Mutation